tiprankstipranks
Rallybio (RLYB)
NASDAQ:RLYB
US Market
RLYB
Rallybio
RESEARCH TOOLSreports

Rallybio (RLYB) Income Statement

360 Followers

Rallybio Income Statement

Last quarter (Q4 2025), Rallybio's total revenue was $222.00K, an increase of 484.21% from the same quarter last year. In Q4, Rallybio's net income was $-5.85M. See Rallybio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 858.00K$ 636.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 766.00K$ 636.00K$ -150.00K$ -167.00K$ -109.00K
Operating Expenses
$ 28.83M$ 61.13M$ 78.93M$ 67.88M$ 45.65M
Depreciation and Amortization
$ 92.00K$ 131.00K$ 150.00K$ 167.00K$ 109.00K
EBITDA
$ -27.97M$ -60.37M$ -78.78M$ -67.72M$ -45.39M
Operating Income
$ -28.06M$ -60.50M$ -78.93M$ -67.88M$ -45.65M
Other Income/Expenses
$ 19.09M$ 2.72M$ 4.37M$ 1.23M$ -1.36M
Pretax Income
$ -8.98M$ -57.77M$ -74.56M$ -67.73M$ -47.01M
Net Income
$ -8.98M$ -57.77M$ -74.56M$ -66.65M$ -47.01M
Per Share Metrics
Basic EPS
$ -1.59$ -10.64$ -14.72$ -16.72$ -11.68
Diluted EPS
$ -1.59$ -10.64$ -14.72$ -16.72$ -11.68
Weighted Average Shares Outstanding
 5.63M 5.44M 5.06M 3.98M 4.02M
Weighted Average Shares Outstanding (Diluted)
 5.63M 5.44M 5.06M 3.98M 4.02M
Currency in USD

Rallybio Earnings and Revenue History